Drug Transporters at the Human Blood-Testis Barrier.

Drug Metab Dispos

College of Pharmacy, Department of Pharmacology & Toxicology (R.K.H., N.J.C.) and College of Medicine, Department of Physiology (S.H.W.), The University of Arizona, Tucson, Arizona

Published: May 2023

AI Article Synopsis

  • Transporters play a crucial role in moving important molecules across cell membranes, impacting drug effectiveness and toxicity, particularly noted in organs like the kidney and liver.
  • The blood-testis barrier (BTB), formed by Sertoli cells, restricts certain substances from entering the testes, highlighting the significance of specific drug transporters in facilitating drug movement across this barrier.
  • Recent research on human testicular transporters is limited, and there are discrepancies in the understanding of transporters in other species, underscoring the need for more comprehensive studies on testicular transport to improve drug disposition and toxicity evaluations.

Article Abstract

Transporters are involved in the movement of many physiologically important molecules across cell membranes and have a substantial impact on the pharmacological and toxicological effect of xenobiotics. Many transporters have been studied in the context of disposition to, or toxicity in, organs such as the kidney and liver; however, transporters in the testes are increasingly gaining recognition for their role in drug transport across the blood-testis barrier (BTB). The BTB is an epithelial membrane barrier formed by adjacent Sertoli cells (SCs) in the seminiferous tubules that form intercellular junctional complexes to protect developing germ cells from the external environment. Consequently, many charged or large polar molecules cannot cross this barrier without assistance from a transporter. SCs express a variety of drug uptake and efflux transporters to control the flux of endogenous and exogenous molecules across the BTB. Recent studies have identified several transport pathways in SCs that allow certain drugs to circumvent the human BTB. These pathways may exist in other species, such as rodents and nonhuman primates; however, there is (1) a lack of information on their expression and/or localization in these species, and (2) conflicting reports on localization of some transporters that have been evaluated in rodents compared with humans. This review outlines the current knowledge on the expression and localization of pharmacologically relevant drug transporters in human testes and calls attention to the insufficient and contradictory understanding of testicular transporters in other species that are commonly used in drug disposition and toxicity studies. SIGNIFICANCE STATEMENT: While the expression, localization, and function of many xenobiotic transporters have been studied in organs such as the kidney and liver, the characterization of transporters in the testes is scarce. This review summarizes the expression and localization of common pharmacologically-relevant transporters in human testes that have significant implications for the development of drugs that can cross the blood-testis barrier. Potential expression differences between humans and rodents highlighted here suggest rodents may be inappropriate for some testicular disposition and toxicity studies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158500PMC
http://dx.doi.org/10.1124/dmd.122.001186DOI Listing

Publication Analysis

Top Keywords

transporters human
12
blood-testis barrier
12
disposition toxicity
12
expression localization
12
transporters
10
drug transporters
8
transporters studied
8
organs kidney
8
kidney liver
8
transporters testes
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!